DR. AGARWAL'S EYE HOSP L Intrinsic Value

DRAGARWQ · Healthcare · Current price ₹5,313

Full stock page
DocStoX fair value
₹2,694
low confidence
Current price
₹5,313
Upside to fair value
-49.3%
Verdict
Avoid
Quality score
5.1 / 10
Model it yourself — Intrinsic Value Calculator
Opens pre-filled with DR. AGARWAL'S EYE HOSP L's latest numbers.

Is DR. AGARWAL'S EYE HOSP L undervalued?

DocStoX estimates the fair value of DR. AGARWAL'S EYE HOSP L at ₹2,694 per share, versus the current market price of ₹5,313. That puts the stock about -49.3% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.

How this fair value is calculated

This estimate blends 4 independent methods: Residual income (₹577), Relative P/E (₹9,384), Graham floor (₹1,204), Analyst target (₹600). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.

Bear, base and bull scenarios

Our scenarios span ₹577 (bear) to ₹2,694 (base) to ₹9,384 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.

Margin of safety

Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹5,313 versus an intrinsic value of ₹2,694, DR. AGARWAL'S EYE HOSP L currently offers -49.3% of negative margin (i.e. a premium).

More on DR. AGARWAL'S EYE HOSP L

Fair ValueDCFValuationFinancial RatiosPeers

DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.